0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Insulin Sensitizers Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-26P12310
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Insulin Sensitizers Market Research Report 2022
BUY CHAPTERS

Global Insulin Sensitizers Market Research Report 2025

Code: QYRE-Auto-26P12310
Report
February 2025
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Insulin Sensitizers Market Size

The global market for Insulin Sensitizers was valued at US$ 15850 million in the year 2024 and is projected to reach a revised size of US$ 23090 million by 2031, growing at a CAGR of 5.6% during the forecast period.

Insulin Sensitizers Market

Insulin Sensitizers Market

Insulin sensitizer, also known as "insulin sensitizer", is a kind of peroxisome proliferator-activated receptor (PPAR) agonist, a special substance that enhances insulin sensitivity in the human body and promotes the full utilization of insulin.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Insulin Sensitizers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Sensitizers.
The Insulin Sensitizers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Insulin Sensitizers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insulin Sensitizers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Insulin Sensitizers Market Report

Report Metric Details
Report Name Insulin Sensitizers Market
Accounted market size in year US$ 15850 million
Forecasted market size in 2031 US$ 23090 million
CAGR 5.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Drugstore
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, Novo Nordisk, Lilly, MSD, Boehringer Ingelheim, Chipscreen Biosciences, Shandong Lukang Pharmaceutical, Zhejiang Hisun Pharmaceutical, SPH Zhongxi Pharmaceutical, Guizhou Shengjitang Pharmaceutical, Chengdu Hengrui Pharmaceutical, Zhejiang Wansheng Pharmaceutical, Shenzhen Neptunus Pharmaceutical, Shanghai Kaibao Pharmaceutical, Hangzhou Conba Pharmaceutical, Glaxosmithkline Pharmaceuticals, Xian Taiji Pharmaceutical, Beijing Taiyang Pharmaceutical, Shandong Zibo Xinda Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Insulin Sensitizers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Insulin Sensitizers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Insulin Sensitizers Market growing?

Ans: The Insulin Sensitizers Market witnessing a CAGR of 5.6% during the forecast period 2025-2031.

What is the Insulin Sensitizers Market size in 2031?

Ans: The Insulin Sensitizers Market size in 2031 will be US$ 23090 million.

Who are the main players in the Insulin Sensitizers Market report?

Ans: The main players in the Insulin Sensitizers Market are Sanofi, Novo Nordisk, Lilly, MSD, Boehringer Ingelheim, Chipscreen Biosciences, Shandong Lukang Pharmaceutical, Zhejiang Hisun Pharmaceutical, SPH Zhongxi Pharmaceutical, Guizhou Shengjitang Pharmaceutical, Chengdu Hengrui Pharmaceutical, Zhejiang Wansheng Pharmaceutical, Shenzhen Neptunus Pharmaceutical, Shanghai Kaibao Pharmaceutical, Hangzhou Conba Pharmaceutical, Glaxosmithkline Pharmaceuticals, Xian Taiji Pharmaceutical, Beijing Taiyang Pharmaceutical, Shandong Zibo Xinda Pharmaceutical

What are the Application segmentation covered in the Insulin Sensitizers Market report?

Ans: The Applications covered in the Insulin Sensitizers Market report are Hospital, Drugstore

What are the Type segmentation covered in the Insulin Sensitizers Market report?

Ans: The Types covered in the Insulin Sensitizers Market report are Thiazolidinediones, Biguanides, Others

Recommended Reports

Insulin & Analogs

Diabetes Therapies

Glycemic Control Drugs

1 Insulin Sensitizers Market Overview
1.1 Product Definition
1.2 Insulin Sensitizers by Type
1.2.1 Global Insulin Sensitizers Market Value Comparison by Type (2024 VS 2031)
1.2.2 Thiazolidinediones
1.2.3 Biguanides
1.2.4 Others
1.3 Insulin Sensitizers by Application
1.3.1 Global Insulin Sensitizers Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drugstore
1.4 Global Insulin Sensitizers Market Size Estimates and Forecasts
1.4.1 Global Insulin Sensitizers Revenue 2020-2031
1.4.2 Global Insulin Sensitizers Sales 2020-2031
1.4.3 Global Insulin Sensitizers Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Insulin Sensitizers Market Competition by Manufacturers
2.1 Global Insulin Sensitizers Sales Market Share by Manufacturers (2020-2025)
2.2 Global Insulin Sensitizers Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Insulin Sensitizers Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Insulin Sensitizers, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Insulin Sensitizers, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insulin Sensitizers, Product Type & Application
2.7 Global Key Manufacturers of Insulin Sensitizers, Date of Enter into This Industry
2.8 Global Insulin Sensitizers Market Competitive Situation and Trends
2.8.1 Global Insulin Sensitizers Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Insulin Sensitizers Players Market Share by Revenue
2.8.3 Global Insulin Sensitizers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Insulin Sensitizers Market Scenario by Region
3.1 Global Insulin Sensitizers Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Insulin Sensitizers Sales by Region: 2020-2031
3.2.1 Global Insulin Sensitizers Sales by Region: 2020-2025
3.2.2 Global Insulin Sensitizers Sales by Region: 2026-2031
3.3 Global Insulin Sensitizers Revenue by Region: 2020-2031
3.3.1 Global Insulin Sensitizers Revenue by Region: 2020-2025
3.3.2 Global Insulin Sensitizers Revenue by Region: 2026-2031
3.4 North America Insulin Sensitizers Market Facts & Figures by Country
3.4.1 North America Insulin Sensitizers Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Insulin Sensitizers Sales by Country (2020-2031)
3.4.3 North America Insulin Sensitizers Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Insulin Sensitizers Market Facts & Figures by Country
3.5.1 Europe Insulin Sensitizers Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Insulin Sensitizers Sales by Country (2020-2031)
3.5.3 Europe Insulin Sensitizers Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Sensitizers Market Facts & Figures by Region
3.6.1 Asia Pacific Insulin Sensitizers Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Insulin Sensitizers Sales by Region (2020-2031)
3.6.3 Asia Pacific Insulin Sensitizers Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Insulin Sensitizers Market Facts & Figures by Country
3.7.1 Latin America Insulin Sensitizers Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Insulin Sensitizers Sales by Country (2020-2031)
3.7.3 Latin America Insulin Sensitizers Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insulin Sensitizers Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Sensitizers Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Insulin Sensitizers Sales by Country (2020-2031)
3.8.3 Middle East and Africa Insulin Sensitizers Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Insulin Sensitizers Sales by Type (2020-2031)
4.1.1 Global Insulin Sensitizers Sales by Type (2020-2025)
4.1.2 Global Insulin Sensitizers Sales by Type (2026-2031)
4.1.3 Global Insulin Sensitizers Sales Market Share by Type (2020-2031)
4.2 Global Insulin Sensitizers Revenue by Type (2020-2031)
4.2.1 Global Insulin Sensitizers Revenue by Type (2020-2025)
4.2.2 Global Insulin Sensitizers Revenue by Type (2026-2031)
4.2.3 Global Insulin Sensitizers Revenue Market Share by Type (2020-2031)
4.3 Global Insulin Sensitizers Price by Type (2020-2031)
5 Segment by Application
5.1 Global Insulin Sensitizers Sales by Application (2020-2031)
5.1.1 Global Insulin Sensitizers Sales by Application (2020-2025)
5.1.2 Global Insulin Sensitizers Sales by Application (2026-2031)
5.1.3 Global Insulin Sensitizers Sales Market Share by Application (2020-2031)
5.2 Global Insulin Sensitizers Revenue by Application (2020-2031)
5.2.1 Global Insulin Sensitizers Revenue by Application (2020-2025)
5.2.2 Global Insulin Sensitizers Revenue by Application (2026-2031)
5.2.3 Global Insulin Sensitizers Revenue Market Share by Application (2020-2031)
5.3 Global Insulin Sensitizers Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Insulin Sensitizers Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Insulin Sensitizers Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Novo Nordisk
6.2.1 Novo Nordisk Company Information
6.2.2 Novo Nordisk Description and Business Overview
6.2.3 Novo Nordisk Insulin Sensitizers Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novo Nordisk Insulin Sensitizers Product Portfolio
6.2.5 Novo Nordisk Recent Developments/Updates
6.3 Lilly
6.3.1 Lilly Company Information
6.3.2 Lilly Description and Business Overview
6.3.3 Lilly Insulin Sensitizers Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Lilly Insulin Sensitizers Product Portfolio
6.3.5 Lilly Recent Developments/Updates
6.4 MSD
6.4.1 MSD Company Information
6.4.2 MSD Description and Business Overview
6.4.3 MSD Insulin Sensitizers Sales, Revenue and Gross Margin (2020-2025)
6.4.4 MSD Insulin Sensitizers Product Portfolio
6.4.5 MSD Recent Developments/Updates
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Company Information
6.5.2 Boehringer Ingelheim Description and Business Overview
6.5.3 Boehringer Ingelheim Insulin Sensitizers Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Boehringer Ingelheim Insulin Sensitizers Product Portfolio
6.5.5 Boehringer Ingelheim Recent Developments/Updates
6.6 Chipscreen Biosciences
6.6.1 Chipscreen Biosciences Company Information
6.6.2 Chipscreen Biosciences Description and Business Overview
6.6.3 Chipscreen Biosciences Insulin Sensitizers Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Chipscreen Biosciences Insulin Sensitizers Product Portfolio
6.6.5 Chipscreen Biosciences Recent Developments/Updates
6.7 Shandong Lukang Pharmaceutical
6.7.1 Shandong Lukang Pharmaceutical Company Information
6.7.2 Shandong Lukang Pharmaceutical Description and Business Overview
6.7.3 Shandong Lukang Pharmaceutical Insulin Sensitizers Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Shandong Lukang Pharmaceutical Insulin Sensitizers Product Portfolio
6.7.5 Shandong Lukang Pharmaceutical Recent Developments/Updates
6.8 Zhejiang Hisun Pharmaceutical
6.8.1 Zhejiang Hisun Pharmaceutical Company Information
6.8.2 Zhejiang Hisun Pharmaceutical Description and Business Overview
6.8.3 Zhejiang Hisun Pharmaceutical Insulin Sensitizers Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Zhejiang Hisun Pharmaceutical Insulin Sensitizers Product Portfolio
6.8.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
6.9 SPH Zhongxi Pharmaceutical
6.9.1 SPH Zhongxi Pharmaceutical Company Information
6.9.2 SPH Zhongxi Pharmaceutical Description and Business Overview
6.9.3 SPH Zhongxi Pharmaceutical Insulin Sensitizers Sales, Revenue and Gross Margin (2020-2025)
6.9.4 SPH Zhongxi Pharmaceutical Insulin Sensitizers Product Portfolio
6.9.5 SPH Zhongxi Pharmaceutical Recent Developments/Updates
6.10 Guizhou Shengjitang Pharmaceutical
6.10.1 Guizhou Shengjitang Pharmaceutical Company Information
6.10.2 Guizhou Shengjitang Pharmaceutical Description and Business Overview
6.10.3 Guizhou Shengjitang Pharmaceutical Insulin Sensitizers Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Guizhou Shengjitang Pharmaceutical Insulin Sensitizers Product Portfolio
6.10.5 Guizhou Shengjitang Pharmaceutical Recent Developments/Updates
6.11 Chengdu Hengrui Pharmaceutical
6.11.1 Chengdu Hengrui Pharmaceutical Company Information
6.11.2 Chengdu Hengrui Pharmaceutical Description and Business Overview
6.11.3 Chengdu Hengrui Pharmaceutical Insulin Sensitizers Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Chengdu Hengrui Pharmaceutical Insulin Sensitizers Product Portfolio
6.11.5 Chengdu Hengrui Pharmaceutical Recent Developments/Updates
6.12 Zhejiang Wansheng Pharmaceutical
6.12.1 Zhejiang Wansheng Pharmaceutical Company Information
6.12.2 Zhejiang Wansheng Pharmaceutical Description and Business Overview
6.12.3 Zhejiang Wansheng Pharmaceutical Insulin Sensitizers Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Zhejiang Wansheng Pharmaceutical Insulin Sensitizers Product Portfolio
6.12.5 Zhejiang Wansheng Pharmaceutical Recent Developments/Updates
6.13 Shenzhen Neptunus Pharmaceutical
6.13.1 Shenzhen Neptunus Pharmaceutical Company Information
6.13.2 Shenzhen Neptunus Pharmaceutical Description and Business Overview
6.13.3 Shenzhen Neptunus Pharmaceutical Insulin Sensitizers Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Shenzhen Neptunus Pharmaceutical Insulin Sensitizers Product Portfolio
6.13.5 Shenzhen Neptunus Pharmaceutical Recent Developments/Updates
6.14 Shanghai Kaibao Pharmaceutical
6.14.1 Shanghai Kaibao Pharmaceutical Company Information
6.14.2 Shanghai Kaibao Pharmaceutical Description and Business Overview
6.14.3 Shanghai Kaibao Pharmaceutical Insulin Sensitizers Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Shanghai Kaibao Pharmaceutical Insulin Sensitizers Product Portfolio
6.14.5 Shanghai Kaibao Pharmaceutical Recent Developments/Updates
6.15 Hangzhou Conba Pharmaceutical
6.15.1 Hangzhou Conba Pharmaceutical Company Information
6.15.2 Hangzhou Conba Pharmaceutical Description and Business Overview
6.15.3 Hangzhou Conba Pharmaceutical Insulin Sensitizers Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Hangzhou Conba Pharmaceutical Insulin Sensitizers Product Portfolio
6.15.5 Hangzhou Conba Pharmaceutical Recent Developments/Updates
6.16 Glaxosmithkline Pharmaceuticals
6.16.1 Glaxosmithkline Pharmaceuticals Company Information
6.16.2 Glaxosmithkline Pharmaceuticals Description and Business Overview
6.16.3 Glaxosmithkline Pharmaceuticals Insulin Sensitizers Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Glaxosmithkline Pharmaceuticals Insulin Sensitizers Product Portfolio
6.16.5 Glaxosmithkline Pharmaceuticals Recent Developments/Updates
6.17 Xian Taiji Pharmaceutical
6.17.1 Xian Taiji Pharmaceutical Company Information
6.17.2 Xian Taiji Pharmaceutical Description and Business Overview
6.17.3 Xian Taiji Pharmaceutical Insulin Sensitizers Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Xian Taiji Pharmaceutical Insulin Sensitizers Product Portfolio
6.17.5 Xian Taiji Pharmaceutical Recent Developments/Updates
6.18 Beijing Taiyang Pharmaceutical
6.18.1 Beijing Taiyang Pharmaceutical Company Information
6.18.2 Beijing Taiyang Pharmaceutical Description and Business Overview
6.18.3 Beijing Taiyang Pharmaceutical Insulin Sensitizers Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Beijing Taiyang Pharmaceutical Insulin Sensitizers Product Portfolio
6.18.5 Beijing Taiyang Pharmaceutical Recent Developments/Updates
6.19 Shandong Zibo Xinda Pharmaceutical
6.19.1 Shandong Zibo Xinda Pharmaceutical Company Information
6.19.2 Shandong Zibo Xinda Pharmaceutical Description and Business Overview
6.19.3 Shandong Zibo Xinda Pharmaceutical Insulin Sensitizers Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Shandong Zibo Xinda Pharmaceutical Insulin Sensitizers Product Portfolio
6.19.5 Shandong Zibo Xinda Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Sensitizers Industry Chain Analysis
7.2 Insulin Sensitizers Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Sensitizers Production Mode & Process Analysis
7.4 Insulin Sensitizers Sales and Marketing
7.4.1 Insulin Sensitizers Sales Channels
7.4.2 Insulin Sensitizers Distributors
7.5 Insulin Sensitizers Customer Analysis
8 Insulin Sensitizers Market Dynamics
8.1 Insulin Sensitizers Industry Trends
8.2 Insulin Sensitizers Market Drivers
8.3 Insulin Sensitizers Market Challenges
8.4 Insulin Sensitizers Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Insulin Sensitizers Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Insulin Sensitizers Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Insulin Sensitizers Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Insulin Sensitizers Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Insulin Sensitizers Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Insulin Sensitizers Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Insulin Sensitizers Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Insulin Sensitizers Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Insulin Sensitizers, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Insulin Sensitizers, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Insulin Sensitizers, Product Type & Application
 Table 12. Global Key Manufacturers of Insulin Sensitizers, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Insulin Sensitizers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Sensitizers as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Insulin Sensitizers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Insulin Sensitizers Sales by Region (2020-2025) & (K Units)
 Table 18. Global Insulin Sensitizers Sales Market Share by Region (2020-2025)
 Table 19. Global Insulin Sensitizers Sales by Region (2026-2031) & (K Units)
 Table 20. Global Insulin Sensitizers Sales Market Share by Region (2026-2031)
 Table 21. Global Insulin Sensitizers Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Insulin Sensitizers Revenue Market Share by Region (2020-2025)
 Table 23. Global Insulin Sensitizers Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Insulin Sensitizers Revenue Market Share by Region (2026-2031)
 Table 25. North America Insulin Sensitizers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Insulin Sensitizers Sales by Country (2020-2025) & (K Units)
 Table 27. North America Insulin Sensitizers Sales by Country (2026-2031) & (K Units)
 Table 28. North America Insulin Sensitizers Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Insulin Sensitizers Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Insulin Sensitizers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Insulin Sensitizers Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Insulin Sensitizers Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Insulin Sensitizers Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Insulin Sensitizers Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Insulin Sensitizers Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Insulin Sensitizers Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Insulin Sensitizers Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Insulin Sensitizers Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Insulin Sensitizers Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Insulin Sensitizers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Insulin Sensitizers Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Insulin Sensitizers Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Insulin Sensitizers Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Insulin Sensitizers Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Insulin Sensitizers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Insulin Sensitizers Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Insulin Sensitizers Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Insulin Sensitizers Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Insulin Sensitizers Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Insulin Sensitizers Sales (K Units) by Type (2020-2025)
 Table 51. Global Insulin Sensitizers Sales (K Units) by Type (2026-2031)
 Table 52. Global Insulin Sensitizers Sales Market Share by Type (2020-2025)
 Table 53. Global Insulin Sensitizers Sales Market Share by Type (2026-2031)
 Table 54. Global Insulin Sensitizers Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Insulin Sensitizers Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Insulin Sensitizers Revenue Market Share by Type (2020-2025)
 Table 57. Global Insulin Sensitizers Revenue Market Share by Type (2026-2031)
 Table 58. Global Insulin Sensitizers Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Insulin Sensitizers Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Insulin Sensitizers Sales (K Units) by Application (2020-2025)
 Table 61. Global Insulin Sensitizers Sales (K Units) by Application (2026-2031)
 Table 62. Global Insulin Sensitizers Sales Market Share by Application (2020-2025)
 Table 63. Global Insulin Sensitizers Sales Market Share by Application (2026-2031)
 Table 64. Global Insulin Sensitizers Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Insulin Sensitizers Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Insulin Sensitizers Revenue Market Share by Application (2020-2025)
 Table 67. Global Insulin Sensitizers Revenue Market Share by Application (2026-2031)
 Table 68. Global Insulin Sensitizers Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Insulin Sensitizers Price (US$/Unit) by Application (2026-2031)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Sanofi Insulin Sensitizers Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. Novo Nordisk Company Information
 Table 76. Novo Nordisk Description and Business Overview
 Table 77. Novo Nordisk Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Novo Nordisk Insulin Sensitizers Product
 Table 79. Novo Nordisk Recent Developments/Updates
 Table 80. Lilly Company Information
 Table 81. Lilly Description and Business Overview
 Table 82. Lilly Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Lilly Insulin Sensitizers Product
 Table 84. Lilly Recent Developments/Updates
 Table 85. MSD Company Information
 Table 86. MSD Description and Business Overview
 Table 87. MSD Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. MSD Insulin Sensitizers Product
 Table 89. MSD Recent Developments/Updates
 Table 90. Boehringer Ingelheim Company Information
 Table 91. Boehringer Ingelheim Description and Business Overview
 Table 92. Boehringer Ingelheim Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Boehringer Ingelheim Insulin Sensitizers Product
 Table 94. Boehringer Ingelheim Recent Developments/Updates
 Table 95. Chipscreen Biosciences Company Information
 Table 96. Chipscreen Biosciences Description and Business Overview
 Table 97. Chipscreen Biosciences Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Chipscreen Biosciences Insulin Sensitizers Product
 Table 99. Chipscreen Biosciences Recent Developments/Updates
 Table 100. Shandong Lukang Pharmaceutical Company Information
 Table 101. Shandong Lukang Pharmaceutical Description and Business Overview
 Table 102. Shandong Lukang Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Shandong Lukang Pharmaceutical Insulin Sensitizers Product
 Table 104. Shandong Lukang Pharmaceutical Recent Developments/Updates
 Table 105. Zhejiang Hisun Pharmaceutical Company Information
 Table 106. Zhejiang Hisun Pharmaceutical Description and Business Overview
 Table 107. Zhejiang Hisun Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Zhejiang Hisun Pharmaceutical Insulin Sensitizers Product
 Table 109. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
 Table 110. SPH Zhongxi Pharmaceutical Company Information
 Table 111. SPH Zhongxi Pharmaceutical Description and Business Overview
 Table 112. SPH Zhongxi Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. SPH Zhongxi Pharmaceutical Insulin Sensitizers Product
 Table 114. SPH Zhongxi Pharmaceutical Recent Developments/Updates
 Table 115. Guizhou Shengjitang Pharmaceutical Company Information
 Table 116. Guizhou Shengjitang Pharmaceutical Description and Business Overview
 Table 117. Guizhou Shengjitang Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Guizhou Shengjitang Pharmaceutical Insulin Sensitizers Product
 Table 119. Guizhou Shengjitang Pharmaceutical Recent Developments/Updates
 Table 120. Chengdu Hengrui Pharmaceutical Company Information
 Table 121. Chengdu Hengrui Pharmaceutical Description and Business Overview
 Table 122. Chengdu Hengrui Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Chengdu Hengrui Pharmaceutical Insulin Sensitizers Product
 Table 124. Chengdu Hengrui Pharmaceutical Recent Developments/Updates
 Table 125. Zhejiang Wansheng Pharmaceutical Company Information
 Table 126. Zhejiang Wansheng Pharmaceutical Description and Business Overview
 Table 127. Zhejiang Wansheng Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Zhejiang Wansheng Pharmaceutical Insulin Sensitizers Product
 Table 129. Zhejiang Wansheng Pharmaceutical Recent Developments/Updates
 Table 130. Shenzhen Neptunus Pharmaceutical Company Information
 Table 131. Shenzhen Neptunus Pharmaceutical Description and Business Overview
 Table 132. Shenzhen Neptunus Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Shenzhen Neptunus Pharmaceutical Insulin Sensitizers Product
 Table 134. Shenzhen Neptunus Pharmaceutical Recent Developments/Updates
 Table 135. Shanghai Kaibao Pharmaceutical Company Information
 Table 136. Shanghai Kaibao Pharmaceutical Description and Business Overview
 Table 137. Shanghai Kaibao Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Shanghai Kaibao Pharmaceutical Insulin Sensitizers Product
 Table 139. Shanghai Kaibao Pharmaceutical Recent Developments/Updates
 Table 140. Hangzhou Conba Pharmaceutical Company Information
 Table 141. Hangzhou Conba Pharmaceutical Description and Business Overview
 Table 142. Hangzhou Conba Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Hangzhou Conba Pharmaceutical Insulin Sensitizers Product
 Table 144. Hangzhou Conba Pharmaceutical Recent Developments/Updates
 Table 145. Glaxosmithkline Pharmaceuticals Company Information
 Table 146. Glaxosmithkline Pharmaceuticals Description and Business Overview
 Table 147. Glaxosmithkline Pharmaceuticals Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Glaxosmithkline Pharmaceuticals Insulin Sensitizers Product
 Table 149. Glaxosmithkline Pharmaceuticals Recent Developments/Updates
 Table 150. Xian Taiji Pharmaceutical Company Information
 Table 151. Xian Taiji Pharmaceutical Description and Business Overview
 Table 152. Xian Taiji Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Xian Taiji Pharmaceutical Insulin Sensitizers Product
 Table 154. Xian Taiji Pharmaceutical Recent Developments/Updates
 Table 155. Beijing Taiyang Pharmaceutical Company Information
 Table 156. Beijing Taiyang Pharmaceutical Description and Business Overview
 Table 157. Beijing Taiyang Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Beijing Taiyang Pharmaceutical Insulin Sensitizers Product
 Table 159. Beijing Taiyang Pharmaceutical Recent Developments/Updates
 Table 160. Shandong Zibo Xinda Pharmaceutical Company Information
 Table 161. Shandong Zibo Xinda Pharmaceutical Description and Business Overview
 Table 162. Shandong Zibo Xinda Pharmaceutical Insulin Sensitizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Shandong Zibo Xinda Pharmaceutical Insulin Sensitizers Product
 Table 164. Shandong Zibo Xinda Pharmaceutical Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. Insulin Sensitizers Distributors List
 Table 168. Insulin Sensitizers Customers List
 Table 169. Insulin Sensitizers Market Trends
 Table 170. Insulin Sensitizers Market Drivers
 Table 171. Insulin Sensitizers Market Challenges
 Table 172. Insulin Sensitizers Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Insulin Sensitizers
 Figure 2. Global Insulin Sensitizers Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Insulin Sensitizers Market Share by Type: 2024 & 2031
 Figure 4. Thiazolidinediones Product Picture
 Figure 5. Biguanides Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Insulin Sensitizers Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Insulin Sensitizers Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Drugstore
 Figure 11. Global Insulin Sensitizers Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Insulin Sensitizers Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Insulin Sensitizers Sales (2020-2031) & (K Units)
 Figure 14. Global Insulin Sensitizers Average Price (US$/Unit) & (2020-2031)
 Figure 15. Insulin Sensitizers Report Years Considered
 Figure 16. Insulin Sensitizers Sales Share by Manufacturers in 2024
 Figure 17. Global Insulin Sensitizers Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Insulin Sensitizers Players: Market Share by Revenue in Insulin Sensitizers in 2024
 Figure 19. Insulin Sensitizers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Insulin Sensitizers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Insulin Sensitizers Sales Market Share by Country (2020-2031)
 Figure 22. North America Insulin Sensitizers Revenue Market Share by Country (2020-2031)
 Figure 23. United States Insulin Sensitizers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Insulin Sensitizers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Insulin Sensitizers Sales Market Share by Country (2020-2031)
 Figure 26. Europe Insulin Sensitizers Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Insulin Sensitizers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Insulin Sensitizers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Insulin Sensitizers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Insulin Sensitizers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Insulin Sensitizers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Insulin Sensitizers Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Insulin Sensitizers Revenue Market Share by Region (2020-2031)
 Figure 34. China Insulin Sensitizers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Insulin Sensitizers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Insulin Sensitizers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Insulin Sensitizers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Insulin Sensitizers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Insulin Sensitizers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Insulin Sensitizers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Insulin Sensitizers Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Insulin Sensitizers Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Insulin Sensitizers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Insulin Sensitizers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Insulin Sensitizers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Insulin Sensitizers Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Insulin Sensitizers Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Insulin Sensitizers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Insulin Sensitizers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Insulin Sensitizers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Insulin Sensitizers by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Insulin Sensitizers by Type (2020-2031)
 Figure 53. Global Insulin Sensitizers Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Insulin Sensitizers by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Insulin Sensitizers by Application (2020-2031)
 Figure 56. Global Insulin Sensitizers Price (US$/Unit) by Application (2020-2031)
 Figure 57. Insulin Sensitizers Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension